How Are Sponsor And Site Employees Dealing With The Technology Tsunami?

Source: Clinical Leader

The COVID-19 pandemic in 2020 quickly changed how clinical trials are conducted. Many companies suddenly needed to switch to decentralized trial models to protect their studies and the safety of participants. Now the main question being asked is where do clinical trials go from here and what can we expect in 2021? And what does the future hold for emerging technologies, virtual trials, and patient centricity in the age of COVID?

In this webinar segment, Jeff Kasher of Patients Can’t Wait and Craig Lipset of Clinical Innovation Partners discuss how employees at sponsor companies and investigator sites are dealing with the explosion of new trial technologies and longer hours. Michelle Longmire of Medable also notes whether decentralized trials will be the new norm in the life sciences industry.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader